Evidence map›Paper›PMID 38503507›Full record

ReviewCold Spring Harbor perspectives in biology2024

Schwann Cell Development and Myelination.

James Salzer, M Laura Feltri, Claire Jacob

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Gene therapy ameliorates neuromuscular pathology in CLN3 disease.Acta neuropathologica communications · 2025
    Article
  16. Neuroprotective Effects and Mechanisms ofInternational journal of molecular sciences · 2025
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

James SalzerNeuroscience Institute, New York University Grossman School of Medicine, New York, New York 10016, USA James.Salzer@nyulangone.org.
M Laura FeltriInstitute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York 14203, USA.
Claire JacobFaculty of Biology, Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University Mainz, Mainz 55128, Germany.
Johannes Gutenberg University Mainz · DENew York University · USUniversity of Milan · IT

Funding

Node of Ranvier Assembly: Role of Axo-Glial InteractionsR01NS043474 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SALZER, JAMES · 2002 to 2024
$7.9M
Regulation of Schwann cell ensheathment and myelination by type III Neuregulin 1R01NS026001 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SALZER, JAMES · 1988 to 2016
$6.5M
Impact of Schwann Cell Pathology on Axon Structure and FunctionR01NS130035 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JAMES SALZER · 2023 to 2026
$2.1M
NINDS NIH HHS R01 NS026001NINDS NIH HHS R01 NS043474NINDS NIH HHS R01 NS130035
6 · The paper itself

Abstract

Glial cells in the peripheral nervous system (PNS), which arise from the neural crest, include axon-associated Schwann cells (SCs) in nerves, synapse-associated SCs at the neuromuscular junction, enteric glia, perikaryon-associated satellite cells in ganglia, and boundary cap cells at the border between the central nervous system (CNS) and the PNS. Here, we focus on axon-associated SCs. These SCs progress through a series of formative stages, which culminate in the generation of myelinating SCs that wrap large-caliber axons and of nonmyelinating (Remak) SCs that enclose multiple, small-caliber axons. In this work, we describe SC development, extrinsic signals from the axon and extracellular matrix (ECM) and the intracellular signaling pathways they activate that regulate SC development, and the morphogenesis and organization of myelinating SCs and the myelin sheath. We review the impact of SCs on the biology and integrity of axons and their emerging role in regulating peripheral nerve architecture. Finally, we explain how transcription and epigenetic factors control and fine-tune SC development and myelination.

Indexed as

AxonsMyelin SheathSchwann CellsAnimalsCell DifferentiationExtracellular MatrixHumansPeripheral Nervous SystemSignal Transduction

Identifiers

PMID38503507
PMCPMC11368196
OpenAlexW4392939982

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.